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The goal of human disease genetics is to
connect genetic variation with disease risk,
but the optimal study design for gene
mapping varies widely with the underlying
genetic architecture of the disease. Family
based linkage studies made the identi-
fication of genetic defects that directly
cause rare single gene diseases, like cystic
fibrosis and sickle cell disease, routine. By
contrast, the goal of identifying the genes
that explain the heritability of complex
diseases has remained elusive because they
are affected by a host of genetic and
environmental factors. More recently,
however, genome-wide association
studies (GWAS) have identified many
common variants associated with complex
traits. In some cases these studies have
provided valuable insight into disease
pathogenesis [1–3] but each associated
variant often confers only a modest
increase in risk (odds ratios [ORs]
typically range from 1.1 to 1.5). One
consequence of these small effects is that,
even in aggregate, these discoveries fail to
explain most of the heritability of complex
disease. Identifying sources of this missing
heritability is one of the most active areas
of complex disease genetics research [4],
and the relative contribution of rare (,1%
minor allele frequency [MAF]), low-fre-
quency (1%–5%), and common (.5%)
causal variants remains unknown. GWAS
have deeply probed the role of common
variation by exploiting the fact that a
subset of single nucleotide polymorphisms
(SNPs) can act as proxies for (or ‘‘tag’’) the
majority of common SNPs. This efficiency
has allowed inexpensive microarrays,
which directly genotype half a million
SNPs, to indirectly capture .80% of
common variation [5]. While this design
underpins the success of the GWAS
approach, it also presents a drawback:
associations to rare and low frequency
SNPs are typically missed because they do
not have a strongly correlated tag on
GWAS chips.
Dickson et al. [6], in a recent simula-
tion-based experiment, argue that com-
mon variant associations arising from
GWAS may actually reflect multiple low
frequency causal variants rather than a
single common causal variant (Figure 1).
They demonstrate that ‘‘synthetic associa-
tions,’’ where a cluster of low-frequency,
highly penetrant mutations occurs stochas-
tically more frequently with one allele than
the other at a common SNP, can cause
association signals at these common vari-
ants. If synthetic associations were wide-
spread they could in theory explain an
appreciable fraction of the missing herita-
bility. Furthermore, the proportion of
GWAS signals attributable to synthetic
associations has profound implications for
the design of GWAS follow-up studies.
Therefore, while Dickson et al. argue that
synthetic associations are an ‘‘obvious
theoretical possibility,’’ it is worthwhile to
broadly assess, in light of other theoretical
and empirical evidence, the prevalence of
synthetic associations in complex human
disease.
NOD2 and Crohn’s Disease: A
Synthetic Association
The synthetic association paradigm is
supported [7] by the well-known associa-
tion between Crohn’s disease and NOD2
[8], where three rare coding variants
(G881R – MAF:0.04, R675W –
MAF:0.01, and L980fs – MAF:0.02)
confer high risk for Crohn’s (ORs for a
carrier and homozygote are 3 and 38,
respectively) [9]. None of these variants
are present on current GWAS arrays, nor
are they individually well-tagged. Never-
theless, extremely strong association is
seen at nearby common variants because
the aggregate effect size of the low-
frequency causal mutations is sufficiently
large that it creates genome-wide signifi-
cant association even at very weak,
common, tag SNPs (Figure 1). For exam-
ple, in the Wellcome Trust Case-Control
Consortium (WTCCC) Crohn’s genome-
wide association study, the most strongly
associated SNP in the region is rs4471699
(P=1.6610
222, risk allele frequency: 0.52,
odds ratio: 1.52) [10]. Furthermore, in a
subset of the WTCCC data where cases
[11] and controls [8,12] have been
genotyped for the three low-frequency
coding mutations, testing for association
while conditioning on carrier status of one
of these mutations completely ablates the
signal at the common SNPs (minimum
unconditional P-value=1.2610
26, condi-
tional P-value=0.52) (Figure 2). Thus,
NOD2 fulfills two important predictions
of the synthetic association model: a
cluster of low-frequency, high-effect vari-
ants can create a GWAS signal, and that
signal vanishes when the causal alleles are
taken into account.
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Detect Synthetic Association
NOD2 also illustrates an important
property of the underlying genetic model
proposed by Dickson et al. [6] that leads to
synthetic association, namely that such loci
should be amenable to linkage mapping.
NOD2 has been consistently mapped by
linkage [13–17], in contrast to nearly all
other reported linkage results for common,
complex human disease. The cluster of
low frequency variants at the NOD2 locus
that confer high risk for disease, which
embodies the synthetic association model
more generally, is highly tractable by
linkage analysis. Therefore, the relative
power of linkage and association can be
used to make inferences about the rate at
which synthetic associations occur.
Recently, the Type-1 Diabetes Genetics
Consortium (T1DGC) conducted a ge-
nome-wide linkage scan of 2,658 affected
sib-pairs with type-1 diabetes [18]. Using
formulae outlined by Risch and Merikan-
gas [19] it is straightforward to assess the
power of this study to detect linkage given a
model specifying the number of risk
variants and their effect sizes. Figure 3
compares, under various models consistent
with synthetic association, the power of the
T1DGC linkage scan to the power of a
GWAS with 2,000 cases and 2,000 controls
[6]. When individual odds ratios are $3, or
there are many independent risk variants,
linkage (rather than association) is the more
powerful approach. If synthetic associations
are common, this observation yields a
testable prediction: either GWAS signals
should overlap substantially with results
from well-powered linkage scans, or all
synthetic associations arise from the rela-
tively small parameter space where linkage
is poorly powered but GWAS is not.
The T1DGC linkage scan shows signifi-
cant linkage to the HLA region on chromo-
some 6p21 (LOD=213.2), and suggestive
linkage (2.2,LOD,3.6) to regions on
chromosomes 2q32, 11p15, 19p13 and
19q12. Because the well-known underlying
genetic effects in the HLA region (OR=5.5)
and 11p15 (INS, OR=2.4) are among the
Figure 1. SNPs in the NOD2 region as an
example of synthetic association. Left
panel represents ten control chromosomes
sampled randomly; right panel represents ten
random Crohn’s disease patient chromosomes.
Colored circles represent variant alleles at SNPs
genotyped on a GWAS chip, colored explosions
represent the three known causal variants in the
gene. While none of the GWAS SNPs are strongly
correlated with any of the individual causal
alleles (the tag SNP theory which underlies the
G W A Sd e s i g n ) ,t h ec o l l e c t i v ee f f e c to ft h et h r e e
causal SNPs is to distort the frequencies of the
GWAS SNPs in cases and controls. This collective
effect of several low frequency SNPs different
distances from a common SNP has been termed
a ‘‘synthetic association.’’
doi:10.1371/journal.pbio.1000580.g001
Figure 2. Evidence of association between Crohn’s disease and the NOD2 region. Grey points: results from a logistic regression test of
association. Black points: results from a logistic regression test of association after conditioning on compound carrier status for three rare NOD2
mutations (highlighted by red triangles). The NOD2 gene region is denoted by the orange track. The complete eradication of the signal at the
common SNPs after conditioning on the rare SNPs demonstrates that the GWAS signal is a synthetic association driven by these rare SNPs.
doi:10.1371/journal.pbio.1000580.g002
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linkage results at these two loci are unsur-
prising. The linkage signal on 2q32 could in
theory be driven by synthetic associations
directly under the peak (CTLA4 (OR=1.2)
and STAT4 (OR=1.1) [20]), but could also
be amplified by three other associations also
on 2q. No documented associations (synthetic
or otherwise) lie under either peak on
chromosome 19. To investigate the possibility
that some GWAS loci may be contained
within regions displaying weak evidence of
linkage (LOD.1.5), we extended the search
to include an extra four such loci but did not
identify any further overlaps. The remaining
47 type 1 diabetes risk loci [20] therefore
show no evidence of linkage. Indeed, for
complex diseases more generally there has
been little overlap in the genomic regions
identified using linkage and association [21].
Thus, either synthetic association is confined
to a relatively narrow set of genetic models
that are detectable only by GWAS or it does
not account for many known associations.
Fine-Mapping of GWAS Regions
Many groups have followed up GWAS
by sequencing associated regions in large
numbers of samples, with the hope of
identifying common causal variants as well
as additional less common, more highly
penetrant mutations. The WTCCC, for
instance, sequenced hundreds of samples in
16 GWAS regions (hundreds of kilobases to
a megabase surrounding the most signifi-
cant SNP), a design that is able to identify
nearby variants causing a synthetic associ-
ation. Indeed, had NOD2 been sequenced,
all three low frequency causal mutations
would have been discovered. No clear
examples of synthetic association were
reported [22], which suggests that synthetic
association is not commonplace. Nonethe-
less it is clear that both low- and high-
frequency alleles do play a role in complex
disease. Nejentsev et al. [23] recently
sequenced several genes identified in a
GWAS of type 1 diabetes in pools of cases,
and discovered four rare coding mutations,
each conferring an approximately two-fold
increase in risk for diabetes. In contrast to
the synthetic association model, however,
these rare SNPs are not correlated with the
common GWAS SNP, and a conditional
analysis including these rare mutations did
not affect the strength of association at the
common GWAS SNP.
The dearth of synthetic associations
reported to date could be due to the low-
frequency variants residing outside the
resequenced interval [7]. For example,
analysis of a GWAS of sickle cell anemia
demonstrated that strong GWAS signals
can be observed at large distances from
causal alleles. The genome-wide signifi-
cant (P,5610
28) signal indeed spans
multiple LD blocks (2.5 Mb in total), due
to the fully penetrant causal (recessive)
genotype, in stark contrast to the small
increase in risk from typical GWAS hits.
Even so, the most associated SNP
(P=1.1610
2136) is within 10 kb of the
Figure 3. Comparative power of linkage and GWAS to detect synthetic association. Solid lines indicate power for the T1DGC linkage
analysis (2,658 affected sibpairs), assuming a risk allele frequency of 0.01, and a=1 610
24, for N=3 (black), 5 (red), or 9 (blue) independent risk alleles.
Dashed lines indicate power to detect these synthetic associations in a GWAS of 3,000 cases and 3,000 controls (data taken from Dickson et al.
Figure 2). Linkage is more powerful than GWAS except for situations with few causal alleles of relatively modest effect.
doi:10.1371/journal.pbio.1000580.g003
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notion that GWAS signals are typically
located close to underlying functional
elements is further supported by their
frequent proximity to candidate genes
associated with related Mendelian condi-
tions or identified by pathway analyses
[24,25]. For example, eight of ten proteins
involved in the Th17-differentiation sig-
naling pathway have been associated with
one or more auto-inflammatory diseases
[26]. Identifying so many candidate genes
within the narrow intervals around GWAS
signals suggests that causal variants are not
routinely located megabases away from
the most strongly associated common
SNP.
While these studies are not exhaustive,
they provide three insights into the
functional architecture of complex disease.
First, both low-and high-frequency risk
alleles can independently exist within a
single locus. Second, GWAS signals often
map closely to underlying functional
elements. Finally, the more general lack
of variants with obvious functional conse-
quences that would explain the association
in GWAS regions suggests that sequencing
of larger sample sets, as well as better
functional annotation of regulatory ele-
ments, will be required.
Population Genetics of
Synthetic Associations
In contrast to common SNPs, most low-
frequency SNPs are not shared across
diverged populations because they have
either arisen relatively recently or their
frequencies have been influenced by
population history (e.g., the out-of-Africa
expansion or natural selection). Since the
synthetic associations proposed by Dickson
et al. are created by low-frequency vari-
ants, they are therefore less likely to be
shared among diverged populations. The
Crohn’s disease synthetic association at
NOD2 is again illustrative, as it is restricted
to populations of European or Jewish
descent [27–29]. The three rare causal
mutations are not observed in Asian
populations, so the common variant
(which is observed at similar frequency to
that seen in individuals of European
descent) is not associated with Crohn’s
disease in individuals of Asian descent. In
contrast, many disease loci initially iden-
tified via GWAS have been widely repli-
cated across divergent populations, sup-
porting the hypothesis that the causal
mutations are, in fact, common [30–32].
Some population-specific GWAS signals
do exist [6], but caution is required in the
interpretation of small-scale, population-
specific replication studies of loci originally
identified in meta-analyses involving thou-
sands of samples. Larger sample sizes from
populations around the world are needed
to resolve the fraction of GWAS hits that
are population-specific.
Conclusions
Complex human diseases are influenced
by common, low-frequency, and rare
mutations, and a hypothesis invoking
multiple rare variants (as proposed by
Dickson) is compatible with the common
disease common variant hypothesis [4].
Large-scale sequencing studies of thou-
sands of cases and controls will be required
to fully understand the genetic architec-
ture of complex disease. Since the preva-
lence of synthetic association acutely
affects the design of these studies (i.e., in
terms of the sample composition and
width of genomic region sequenced) it is
worth carefully evaluating its contribution
to missing heritability. The balance of
current evidence suggests that this contri-
bution is likely to be small. Linkage results,
preliminary evidence from targeted se-
quencing studies, pathway analyses and
transcontinental replication indicate that
common SNP associations arising from
GWAS are just that: common SNP
associations.
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Box 1. Glossary
Odds ratio: the ratio of odds of disease between two groups that differ for a
variable of interest. In genetics, the variable is genotype at a particular location in
the genome; therefore the odds ratio is a measurement of the effect size of that
genetic variant on disease risk. Single-gene disorders, where a particular mutation
essentially guarantees disease, have infinitely large odds ratios, whereas common
risk variants for complex diseases typically have odds ratios around 1.1–1.5.
Linkage study: a gene-mapping approach that searches for genomic segments
that are co-inherited with disease within a family. Linkage scans have been most
successful in the study of diseases caused by rare mutations in a single gene.
Association study: another gene-mapping study design based on comparing
allele frequencies between cases and controls. Inexpensive genotyping technol-
ogies coupled with large patient collections (thousands of individuals with a
disease) have enabled genome-wide association studies that are well suited to
detecting small effects at common SNPs.
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